NYSE:ZTSPharmaceuticals
Zoetis (ZTS): Exploring Valuation as Decade-Long Dividend Growth Signals Financial Strength
Zoetis (NYSE:ZTS) has once again reaffirmed its commitment to shareholders by announcing a fourth-quarter dividend of $0.50 per share. This consistent dividend policy has continued for over a decade and signals ongoing financial stability.
See our latest analysis for Zoetis.
Even with Zoetis making headlines for its steady dividends and the FDA’s recent conditional approval of its new Dectomax-CA1 treatment for cattle, the stock’s momentum has faded this year. The 1-year total shareholder...